SINGER JAMES R 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-01-05 3:12 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
SINGER JAMES R | 3,000,000 4.700% |
150,000![]() (+5.26%) |
Filing |